Off-label use of prescription medications, a common practice that healthcare providers have long relied on and that pharmaceutical companies have profited from, has become the subject of a great deal of controversy. Billions in settlements have been paid out to patients who were allegedly harmed as a result of the off-label... Read more »

On March 27, 2015, a former Risperdal patient filed a lawsuit in U.S. District Court for the Eastern District of Louisiana against several drug manufacturers, including Janssen Pharmaceuticals and Johnson & Johnson. The complaint is one of several ongoing causes of action against the makers of the powerful antipsychotic drug, which... Read more »

A Risperdal lawsuit that was pending in a Philadelphia court resulted in a mixed outcome for the plaintiff. The 19-year-old man filed the lawsuit against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, claiming that the defendants’ medication resulted in the abnormal growth of breast tissue. On Friday, March 20, the... Read more »

The drug Risperdal is a powerful antipsychotic medication originally designed and manufactured to treat otherwise-untreatable symptoms of adult schizophrenia. The drug was historically considered an option of last resort, as it carries a risk of several other side effects that could place patients in grave danger of injury or death.... Read more »

A Philadelphia law firm has filed a Risperdal lawsuit against the Department of Health and Human Services and the Food and Drug Administration. The firm represents hundreds of children who have been allegedly injured as a result of ingesting Risperdal. The antipsychotic drug is used to treat a variety of mental/mood... Read more »

The drug known as Risperdal – which is a highly-powerful antipsychotic treatment option manufactured and marketed by Johnson & Johnson and Janssen Pharmaceuticals – has been implicated in yet another lawsuit alleging the unlawful promotion and marketing of the product, as well as an intentional and unlawful failure to disclose... Read more »

Another Risperdal lawsuit over gynecomastia has been filed, this time in Louisiana. Karon-Jahlil Williams v. Janssen Pharmaceuticals, Inc., Johnson & Johnson, and Janssen Research and Development, L.L.C. (Case # 5:14-cv-03354) was filed on December 2, 2014 in the US. District Court for the Western District of Louisiana (Shreveport Division). The... Read more »

The powerful prescription medication Risperdal, which is classified as an “atypical antipsychotic,” was recently implicated in a federal personal injury lawsuit filed in United States District Court for the Middle District of Louisiana. At the heart of the plaintiff’s complaint is the assertion that her minor child was wrongfully exposed... Read more »

As the wave of lawsuits involving antipsychotic drug Risperdal continues to gain momentum, several key cases are slated for trial in the coming months in Pennsylvania state court. These suits involve allegations made on behalf of males who suffered excessive breast development after taking the medication in their youth. Johnson &... Read more »

According to the findings of a new study, published by the Journal of Clinical Psychopharmacology, the powerful antipsychotic drug Risperdal shows a positive correlation to the development of abnormal breast tissue in men – a condition known as gynecomastia. The study specifically concluded that the risk of gynecomastia extends not... Read more »